NO961724L - Transdermal administreringsform av nitroglycerin for å forhindre uönskede veer - Google Patents

Transdermal administreringsform av nitroglycerin for å forhindre uönskede veer

Info

Publication number
NO961724L
NO961724L NO961724A NO961724A NO961724L NO 961724 L NO961724 L NO 961724L NO 961724 A NO961724 A NO 961724A NO 961724 A NO961724 A NO 961724A NO 961724 L NO961724 L NO 961724L
Authority
NO
Norway
Prior art keywords
pct
nitroglycerin
transdermal administration
prevent unwanted
sec
Prior art date
Application number
NO961724A
Other languages
English (en)
Norwegian (no)
Other versions
NO961724D0 (no
Inventor
Hans-Michael Wolff
Dietrich Schacht
Martin Feelisch
Bruce Ramsay
John Francis Martin
Christoph Christopher Lees
Adam Julian De Belder
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of NO961724D0 publication Critical patent/NO961724D0/no
Publication of NO961724L publication Critical patent/NO961724L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO961724A 1994-02-28 1996-04-29 Transdermal administreringsform av nitroglycerin for å forhindre uönskede veer NO961724L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4406332A DE4406332C1 (de) 1994-02-28 1994-02-28 Pharmazeutische Verwendung von Nitroglycerin zur Verhinderung unerwünschter Wehentätigkeit bei Säugern in einer transdermalen Applikationsform
PCT/EP1995/000654 WO1995022964A1 (de) 1994-02-28 1995-02-23 Transdermale darreichungsform von nitroglycerin zur verhinderung unerwünschter wehentätigkeit

Publications (2)

Publication Number Publication Date
NO961724D0 NO961724D0 (no) 1996-04-29
NO961724L true NO961724L (no) 1996-04-29

Family

ID=6511303

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961724A NO961724L (no) 1994-02-28 1996-04-29 Transdermal administreringsform av nitroglycerin for å forhindre uönskede veer

Country Status (15)

Country Link
US (1) US5817697A (es)
EP (1) EP0804176B1 (es)
JP (1) JP2823700B2 (es)
KR (1) KR100334372B1 (es)
CN (1) CN1069522C (es)
AT (1) ATE200732T1 (es)
CA (1) CA2184201A1 (es)
DE (2) DE4406332C1 (es)
DK (1) DK0804176T3 (es)
ES (1) ES2156938T3 (es)
FI (1) FI963329A (es)
GR (1) GR3035785T3 (es)
NO (1) NO961724L (es)
PT (1) PT804176E (es)
WO (1) WO1995022964A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020015951A1 (en) * 2000-01-06 2002-02-07 Bader Joel S. Method of analyzing a nucleic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79183B (es) * 1983-04-27 1984-10-02 Lohmann Gmbh & Co Kg
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
EP0518113A1 (de) * 1991-06-10 1992-12-16 Schwarz Pharma Ag Nitroglycerin-Pflaster und Verfahren zu seiner Herstellung
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
JPH1192367A (ja) * 1997-09-22 1999-04-06 Hoechst Marion Roussel Kk 妊娠悪阻治療剤

Also Published As

Publication number Publication date
US5817697A (en) 1998-10-06
DE4406332C1 (de) 1995-06-22
JP2823700B2 (ja) 1998-11-11
ATE200732T1 (de) 2001-05-15
KR100334372B1 (ko) 2002-09-04
DE59509223D1 (de) 2001-05-31
NO961724D0 (no) 1996-04-29
CN1069522C (zh) 2001-08-15
FI963329A (fi) 1996-09-05
CN1140990A (zh) 1997-01-22
WO1995022964A1 (de) 1995-08-31
DK0804176T3 (da) 2001-05-28
JPH09506108A (ja) 1997-06-17
EP0804176A1 (de) 1997-11-05
FI963329A0 (fi) 1996-08-27
GR3035785T3 (en) 2001-07-31
PT804176E (pt) 2001-08-30
ES2156938T3 (es) 2001-08-01
KR960705553A (ko) 1996-11-08
EP0804176B1 (de) 2001-04-25
CA2184201A1 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
DK0799209T3 (da) Sulfonamider
BR9909358A (pt) Composto, composição farmacêutica, e, processo para prevenção ou alìvio de complicações crÈnicas decorrentes de diabetes melito
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
CA2254061A1 (en) Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
HUP0004780A2 (hu) Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében
BE901301A (fr) 5-pyrimidine-carboxamides et thiocarboamides, ainsi que le traitement de la leucemie et des tumeurs avec ces substances.
IL113024A (en) Quinazolinyl-amino derivatives having alpha-antagonist activity their preparation and pharmaceutical compositions comprising them
FR2639225B1 (fr) Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
NO961724L (no) Transdermal administreringsform av nitroglycerin for å forhindre uönskede veer
ES2182975T3 (es) Nueva quimica heterociclica.
NO943567L (no) Bruede bis-arylcarbinolderivater, preparater og anvendelsesmetoder
ATE173922T1 (de) 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
MX9206138A (es) Procedimiento para preparar (s) (+)-4-4'-(1-metil-1-2-etanodiilo)-bis(2,6-piperazinodiona).
KR920003970A (ko) 혈중 요산 함량의 강하 방법
KR900701273A (ko) 진토성 에르골린 유도체
DE59504643D1 (de) Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
ES2194907T3 (es) Utilizacion de la espiramicina en desordenes gastro-intestinales debido al h.pylori.
ES402468A1 (es) Un procedimiento para la preparacion de vincamina y compuestos semejantes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application